BarbeauA.L-Dopa and juvenile Huntington's Disease. Lancet1969;II:1066
2.
BealM.F.KowallN.W.EllinsonD.W.MazurekM.F.SwartzK.J.And Martin, J.B. Replication of the neurochemical characteristics of Huntington's Disease by quinolinic acid. Nature1986; 321:168–171
3.
BelendiukL.BelendiukG.W.And Freedman, D.X. Blood monoamine metabolism in Huntington's Disease. Archives of General Psychiatry1980;37:325–332
4.
BomanB.L-tryptophan: A rational anti-depressant and a natural hypnotic. Australian and New Zealand Journal of Psychiatry1988;22:83–97
5.
BucciL.Ioppolo, A., Chiaverelli, A.R. and Bigotti, A., The central nervous system toxicity of long-term oral administration of L-tryptophan to porto-caval-shunted rats. British Journal of Experimental Pathology1982;63:235–241
6.
DuringM.J.FreezeA.HeyesM.P.SwartzK.J.MarkeyS.P.RothR.H.MartinJ.B.Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid: Effect of systemic tryptophan administration. Submitted for publication
7.
GousinD.B.Central nervous system hypersensitivity to tryptophan. American Journal of Clinical Nutrition1971;24:821–825
8.
SchwarczR.BrushG.S.FosterA.C.And French, E.D. Seizure activity and lesions after intrahippocampal quinolinic acid injections. Experimental Neurology1984;84:1–17
9.
StoneT.W.And Perkins, M.N., Quinolinic Acid: A potent endogenous excitant at amino acid receptors in the rat brain. European Journal of Pharmacology1981;72:411–412
10.
WhetsellW.O., The use of organotypic tissue culture for the study of amino acid neurotoxicity and its antagonism in the mammalian CNS. Clinical Neuropharmacology1984;7:248–250
11.
LawrenceJ. The psychiatry of leadership and the psychiatrist as leader. Australian and New Zealand Journal of Psychiatry1988; 22: 246–256
12.
Schioldann-NielsenJ. The life of D.G.Monrad 1811–1887. Manic-depressive disorder and political leadership. Odense University Press, 1988
13.
Lange-EichbaumWKurthW. Genie, Irrsinn und Ruhm: Genie-Mythus und Pathographie des Genies. Munich: Reinhardt Verlag, 1967 (6th ed. 1979)
14.
GilbertJB. Disease and destiny: A bibliography of medical references to the famous. London: Dawsons, 1962
15.
GilmoreW. Psychohistorical inquiry: A comprehensive research bibliography. New York: Garland, 1984
16.
Schioldann-NielsenJ. Famous and very important persons. Medical, psychological, psychiatric bibliography, 1960–1984. Odense: Odense University Press, 1986
17.
RoosCA. Physicians to the Presidents, and their patients: A bibliography. Bulletin of the Medical Library Association1961; 49:292–360
18.
GreenblattM. Power and the impairment of great leaders. American Journal of Social Psychiatry1984; 4: 11–18
19.
WeinsteinE. Woodrow Wilson: A medical and psychological biography. Princeton University Press, 1981
20.
The United States Congress.Senate. Committee on the Judiciary. Subcommittee on constitutional amendments. Presidential inability; hearings before the Subcommittee … of the Committee … Eighty-eighth Congress, S.J. Res. 28, S.J. Res. 35 and S.J. Res. 84 relating to the problem of presidential inability, June 11 and June 18, 1963. Washington: U.S. Government Printing Office, 1963
21.
BorosonW. Beyond the Twenty-fifth Amendment. Fact1966: Sept/Oct
22.
Group for the Advancement of Psychiatry, Committee on Government Agencies.The VIP with psychiatric impairment. Vol. 8, Report No. 83. New York, 1973
23.
TorreMP. Psychopathology and political leadership. American Journal of Psychotherapy1970; 24: 611–626
24.
GambillJ. Potential problems of detecting and treating psychosis in the White House. Potential psychosis in the White House. International Journal of Social Psychiatry1980; 26: 255–262
25.
WalshM. Historical responsibility of the psychiatrist. Archives of General Psychiatry1964; 11: 355–9
26.
LordMoran. Winston Churchill. The struggle for survival 1940–1965. Taken from the diaries of Lord Moran. London: Constable, 1966
27.
MinasI.H.Persistent psychotic symptoms at discharge in patients with schizophrenia. Australian and New Zealand Journal of Psychiatry1988; 22: 166–172
28.
DarcyL. Tardive dyskinesia clinic. Australian and New Zealand Journal of Psychiatry1988; 22: 325
29.
KalachnikJELarumJGSwansonA. A tardive dyskinesia monitoring policy for applied facilities. Psychopharmacology Bulletin1983; 19:277–282
30.
EllardJ. Where we are, and where we are going. Australian and New Zealand Journal of Psychiatry1988; 22: 258–263
31.
Historical Notes.The word “psychiatry”. American Journal of Psychiatry1951; 107: 868–869
32.
StrömgrenE. [Who has first used the word “psychiatry”]. Medicinsk Forum (Copenhagen)1952; 5:238–240
33.
MechlerA. Das Wort “Psychiatrie”. Historische Anmerkungen. Nervenarzt1963; 34:405–406
34.
PelicierY. Histoire de la psychiatrie. Presses Universitaires de France, 1971